CLDN19 Gene Hypomagnesemia Type 5 Genetic Test sale cost 4400 AED
HOGA1 Gene Hyperoxaluria Type 3 Genetic Test sale cost 4400 AED HOGA1 Gene Hyperoxaluria Type 3 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
ITGB1 Gene Leukocyte Adhesion Deficiency Genetic Test sale cost 4400 AED ITGB1 Gene Leukocyte Adhesion Deficiency Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

CLDN19 Gene Hypomagnesemia Type 5 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CLDN19 gene hypomagnesemia type 5 genetic test is a specialized diagnostic tool designed to identify mutations in the CLDN19 gene, which are known to cause hypomagnesemia type 5. This condition is characterized by low levels of magnesium in the blood, which can lead to a range of symptoms including muscle spasms, seizures, and abnormal heart rhythms. The test is crucial for individuals showing symptoms of magnesium deficiency or those with a family history of hypomagnesemia type 5, as early detection can significantly improve management and treatment outcomes.

Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test offers a comprehensive analysis of the CLDN19 gene to pinpoint any mutations responsible for the condition. The cost of the test is set at 4400 AED, reflecting the advanced technology and expertise required to accurately identify the genetic variations associated with hypomagnesemia type 5.

By opting for this genetic test, patients and healthcare providers can gain valuable insights into the genetic underpinnings of hypomagnesemia type 5, enabling personalized treatment plans and preventive measures to mitigate the impact of this condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CLDN19 Gene Hypomagnesemia type 5 Genetic Test

Test Name: CLDN19 Gene Hypomagnesemia type 5 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Metabolic Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for CLDN19 Gene Hypomagnesemia type 5 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Hypomagnesemia type 5.

Test Details

The CLDN19 gene is associated with a condition called hypomagnesemia type 5. Hypomagnesemia is a condition characterized by low levels of magnesium in the blood. This type of hypomagnesemia is caused by mutations in the CLDN19 gene.

NGS (Next Generation Sequencing) genetic testing is a type of genetic testing that allows for the sequencing of multiple genes simultaneously. It is a powerful tool that can identify mutations or variations in the CLDN19 gene that may be causing hypomagnesemia type 5.

NGS genetic testing for CLDN19 gene mutations can be used to diagnose individuals with hypomagnesemia type 5 and to identify carriers of the mutation. It can also be used for prenatal testing in families with a known CLDN19 gene mutation.

Genetic testing can provide valuable information for the management and treatment of individuals with hypomagnesemia type 5. It can help guide medical interventions and inform genetic counseling for affected individuals and their families.

Test Name CLDN19 Gene Hypomagnesemia type 5 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CLDN19 Gene Hypomagnesemia type 5 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Hypomagnesemia type 5
Test Details

The CLDN19 gene is associated with a condition called hypomagnesemia type 5. Hypomagnesemia is a condition characterized by low levels of magnesium in the blood. This type of hypomagnesemia is caused by mutations in the CLDN19 gene.

NGS (Next Generation Sequencing) genetic testing is a type of genetic testing that allows for the sequencing of multiple genes simultaneously. It is a powerful tool that can identify mutations or variations in the CLDN19 gene that may be causing hypomagnesemia type 5.

NGS genetic testing for CLDN19 gene mutations can be used to diagnose individuals with hypomagnesemia type 5 and to identify carriers of the mutation. It can also be used for prenatal testing in families with a known CLDN19 gene mutation.

Genetic testing can provide valuable information for the management and treatment of individuals with hypomagnesemia type 5. It can help guide medical interventions and inform genetic counseling for affected individuals and their families.

SKU: TEST-2474 Category:

Related products